What is lupus disease? Symptoms, causes and treatment

Lupus is an autoimmune disease where the body’s immune system becomes overly active and attacks normal, healthy tissue. The condition is chronic and ranges from mild to severe. Lupus can affect any part of the body – so it could affect the skin, joints or internal organs.

There are two main types of lupus. Systemic lupus erythematosus is the most common and can affect many parts of a person’s body, including the kidneys, heart, lungs, brain, blood and skin. Discoid lupus, on the other hand, only affects the skin.

Lupus UK estimates that around 50,000 people have lupus in the UK.

Few AIM-listed drug development companies have late-stage clinical assets in the pipeline, ImmuPharma plc (LON:IMM) is an exception. The Company’s lead compound, Lupuzor™, a potential treatment for Lupus, has completed Phase 3 trial of dosing patients across the US, Europe and Mauritius with top line results announced.

Disclaimer

You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.
You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website. More Info.